{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:30:15Z","timestamp":1774438215529,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T00:00:00Z","timestamp":1470096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.theisn.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.kint.2016.04.019","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T01:36:01Z","timestamp":1466904961000},"page":"696-704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Treatment with patiromer decreases aldosterone in\u00a0patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors"],"prefix":"10.1016","volume":"90","author":[{"given":"Matthew R.","family":"Weir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coleman","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha R.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahlia","family":"Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Stasiv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon H.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2016.04.019_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3909\/ricm0782","article-title":"Novel agents for the prevention and management of hyperkalemia","volume":"16","author":"McCullough","year":"2015","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.kint.2016.04.019_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.04.019_bib3","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.04.019_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.114.03231","article-title":"Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk","volume":"63","author":"Brown","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2016.04.019_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.HYP.0000174329.99569.52","article-title":"Cardiovascular benefits of aldosterone receptor antagonists: what about potassium?","volume":"46","author":"Williams","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2016.04.019_bib6","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2016.04.019_bib7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.04.019_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.04.019_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.semnephrol.2014.04.008","article-title":"Prediction and management of hyperkalemia across the spectrum of chronic kidney disease","volume":"34","author":"Lazich","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2016.04.019_bib10","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2009-2521","article-title":"Aldosterone production and insulin resistance in healthy adults","volume":"95","author":"Garg","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.04.019_bib11","doi-asserted-by":"crossref","first-page":"e000018","DOI":"10.1161\/JAHA.112.000018","article-title":"Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism","volume":"2","author":"McGraw","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2016.04.019_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/ATVBAHA.113.302854","article-title":"Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors","volume":"34","author":"Pruthi","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2016.04.019_bib13","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.04.019_bib14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.04.019_bib15","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1681\/ASN.2013030273","article-title":"Long-term effects of spironolactone in peritoneal dialysis patients","volume":"25","author":"Ito","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.04.019_bib16","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3109\/08860220903216121","article-title":"Effect of spironolactone on urinary protein excretion in patients with chronic kidney disease","volume":"31","author":"Sengul","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.kint.2016.04.019_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0002-9343(01)00642-8","article-title":"Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases","volume":"110","author":"Schepkens","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2016.04.019_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11906-011-0202-2","article-title":"Mineralocorticoid receptor blockade in chronic kidney disease","volume":"13","author":"Volk","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.kint.2016.04.019_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.ackd.2014.08.003","article-title":"Aldosterone blockade in CKD: emphasis on pharmacology","volume":"22","author":"Schwenk","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2016.04.019_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2016.04.019_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9343(72)90156-8","article-title":"Aldosterone biosynthesis: interrelationship of regulatory factors","volume":"53","author":"Williams","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2016.04.019_bib22","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1210\/jc.2003-030490","article-title":"50th anniversary of aldosterone","volume":"88","author":"Williams","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.04.019_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/jappl.1970.28.3.299","article-title":"Influence of dietary potassium on plasma renin activity in normal man","volume":"28","author":"Dluhy","year":"1970","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.kint.2016.04.019_bib24","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1172\/JCI107001","article-title":"Studies of the control of plasma aldosterone concentration in normal man: II. Effect of dietary potassium and acute potassium infusion","volume":"51","author":"Dluhy","year":"1972","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.04.019_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1210\/jcem-41-1-153","article-title":"Potassim-aldosterone-renin interrelationships","volume":"41","author":"Himathongkam","year":"1975","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.04.019_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/jcem-45-1-141","article-title":"Effect of simultaneous potassium and saline loading on plasma aldosterone levels","volume":"45","author":"Dluhy","year":"1977","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.04.019_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/jcem-45-1-55","article-title":"Effects of dietary sodium and potassium intake and acute stimulation on aldosterone output by isolated human adrenal cells","volume":"45","author":"Williams","year":"1977","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2016.04.019_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/07435808709035467","article-title":"Changes in adrenal responsiveness and potassium balance with shifts in sodium intake","volume":"13","author":"Adler","year":"1987","journal-title":"Endocr Res"},{"key":"10.1016\/j.kint.2016.04.019_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/1470320311417272","article-title":"Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy","volume":"13","author":"Persson","year":"2011","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.kint.2016.04.019_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jash.2012.07.003","article-title":"Aldosterone breakthrough during aliskiren, valsartan and combination (aliskiren+valsartan) therapy","volume":"6","author":"Bomback","year":"2012","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.kint.2016.04.019_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: the AMETHYST-DN randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2016.04.019_bib32","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/ki.2015.270","article-title":"Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia","volume":"88","author":"Bushinsky","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.04.019_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A\u00a0phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.04.019_bib34","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2215\/CJN.03640415","article-title":"Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD","volume":"10","author":"Lepage","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2016.04.019_bib35","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1172\/JCI118812","article-title":"Role of Ca2+ in the action of adrenocorticotropin in cultured human adrenal glomerulosa cells","volume":"98","author":"Gallo-Payet","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2016.04.019_bib36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/HYPERTENSIONAHA.110.158311","article-title":"Angiotensin II regulates adrenal vascular tone through zona glomerulosa cell-derived EETs and DHETs","volume":"57","author":"Kopf","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2016.04.019_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10741-005-2343-3","article-title":"Aldosterone biosynthesis, regulation, and classical mechanism of action","volume":"10","author":"Williams","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.kint.2016.04.019_bib38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/ki.1973.115","article-title":"Studies on the metabolism of aldosterone in chronic renal failure and anephric man","volume":"4","author":"Williams","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2016.04.019_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1074248416629549","article-title":"Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia [e-pub ahead of\u00a0print]","author":"Li","year":"2016","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.kint.2016.04.019_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJM197209212871201","article-title":"Isolated hypoaldosteronism in adults. A renin-deficiency syndrome","volume":"287","author":"Schambelan","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2016.04.019_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000180491","article-title":"Role of the renin-angiotensin-aldosterone system in the regulation of plasma potassium in chronic renal disease","volume":"15","author":"Weidmann","year":"1975","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2016.04.019_bib42","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2016.04.019_bib43","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1210\/en.2006-0944","article-title":"Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus","volume":"147","author":"Guo","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.kint.2016.04.019_bib44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajh\/hpt276","article-title":"Association of renin and aldosterone with ethnicity and blood pressure: the Multi-Ethnic Study of Atherosclerosis","volume":"27","author":"Rifkin","year":"2014","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.kint.2016.04.019_bib45","first-page":"848","article-title":"The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis","volume":"79","author":"Underwood","year":"1972","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.kint.2016.04.019_bib46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1365-2265.2011.03991.x","article-title":"The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians","volume":"4","author":"Vaidya","year":"2011","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816301867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253816301867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T01:30:45Z","timestamp":1656725445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253816301867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0085253816301867"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2016.04.019","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726468850.793529343","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with patiromer decreases aldosterone in\u00a0patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2016.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}